stockrowBio-Rad Laboratories, Inc.
BIO Healthcare Medical Devices
Bio-Rad Laboratories, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.6 billion, up 0.65% from fiscal 2024.
- Revenue
- +0.52%
- EPS
- +234.9%
- Free cash flow
- +8.07%
- Total debt
- +0.11%
Quarter to September 2026, against a year earlier
Follow BIO
Alert me
Bio-Rad Laboratories, Inc. (BIO) Revenue growth
Bio-Rad Laboratories, Inc.'s revenue growth over the twelve months to 30 September 2026 was 1.38%, up 0.7 percentage points from fiscal 2025 (0.65%). Over the past ten years it has ranged from −7.15% (fiscal 2015) to 14.8% (fiscal 2021); the current reading is higher than 45% of that period. That is below the Medical Devices industry median of 10.4% and below the Healthcare sector median of 7.80%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 0.65% | 4.57 |
| FY2024 | −3.92% | 0.75 |
| FY2023 | −4.67% | (0.55) |
| FY2022 | −4.12% | (18.93) |
| FY2021 | 14.8% | 4.69 |
| FY2020 | 10.1% | 9.15 |
| FY2019 | 0.97% | (5.01) |
| FY2018 | 5.98% | 1.53 |
| FY2017 | 4.45% | 2.04 |
| FY2016 | 2.41% | 9.56 |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Sep 2026 | 0.52% | 0.61 |
| Jun 2026 | −0.09% | (1.23) |
| Mar 2026 | 1.14% | (2.71) |
| Dec 2025 | 3.85% | 3.34 |
| 43 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| GKOS Glaukos Corporation compare | 46.9% |
| PODD Insulet Corporation compare | 26.5% |
| PEN Penumbra, Inc. compare | 17.0% |
| GMED Globus Medical, Inc. compare | 13.4% |
| SNN Smith & Nephew SNATS, Inc. compare | 4.81% |
| BRKR Bruker Corporation compare | 2.16% |
| BIO.B Bio-Rad Laboratories, Inc. compare | 1.38% |
| BIO Bio-Rad Laboratories, Inc. | 1.38% |
| TXG 10x Genomics compare | −4.28% |
| Medical Devices industry median | 10.4% |
| Healthcare sector median | 7.80% |
| Market median | 7.58% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on BIO
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement